Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Regulatory Roundup: Updates on 2 recalls, a new heart valve & more | Nontraditional risk factors & AVR
Thursday, December 1, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Regulatory Roundup: Updates on Medtronic and LivaNova recalls, FDA-cleared AI models, a new heart valve and more

Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.

READ MORE >
Anteris Technologies duravr heart valve
Share on Twitter Share on Facebook Share on Linkedin

Regulatory Roundup: Updates on Medtronic and LivaNova recalls, FDA-cleared AI models, a new heart valve and more

Share on Twitter Share on Facebook Share on Linkedin
Anteris Technologies duravr heart valve
Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.
READ MORE >

Socioeconomic status and mental health make a big impact on AVR outcomes

Nontraditional risk factors such as dementia, PTSD, bipolar disorder and low socioeconomic status are all important to consider when patients are candidates for aortic valve replacement. 

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Socioeconomic status and mental health make a big impact on AVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Nontraditional risk factors such as dementia, PTSD, bipolar disorder and low socioeconomic status are all important to consider when patients are candidates for aortic valve replacement. 
READ MORE >

Featured Articles

Medtronic’s newest self-expanding TAVR system linked to improved performance

Medtronic presented the real-world data at the PCR London Valves 2022 conference. The company's Evolut FX TAVR system gained FDA approval back in August 2021. 

READ MORE >
Medtronic launches Evolut FX TAVR system aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s newest self-expanding TAVR system linked to improved performance

Share on Twitter Share on Facebook Share on Linkedin
Medtronic launches Evolut FX TAVR system aortic stenosis.
Medtronic presented the real-world data at the PCR London Valves 2022 conference. The company's Evolut FX TAVR system gained FDA approval back in August 2021. 
READ MORE >

Radial artery grafts vs. saphenous vein grafts for CABG: Does one outperform the other?

The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona. 

READ MORE >
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
Share on Twitter Share on Facebook Share on Linkedin

Radial artery grafts vs. saphenous vein grafts for CABG: Does one outperform the other?

Share on Twitter Share on Facebook Share on Linkedin
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona. 
READ MORE >

ADHD medications and CVD: Lessons learned from a new meta-analysis of nearly 4 million patients

The new study, published in JAMA Network Open, should help ease any concerns patients may have about regularly taking ADHD medications. 

READ MORE >
middle age patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

ADHD medications and CVD: Lessons learned from a new meta-analysis of nearly 4 million patients

Share on Twitter Share on Facebook Share on Linkedin
middle age patient and doctor
The new study, published in JAMA Network Open, should help ease any concerns patients may have about regularly taking ADHD medications. 
READ MORE >

In Case You Missed It

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 

READ MORE >
Smartphone mHealth. Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
Share on Twitter Share on Facebook Share on Linkedin

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Share on Twitter Share on Facebook Share on Linkedin
Smartphone mHealth. Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 
READ MORE >

In Other News

Flu season is raging in the US—and hospitalizations are rising

This year’s flu season is underway in the United States, and the number of cases is rising, according to the latest flu data from the Centers for Disease Control and Prevention (CDC).

READ MORE >
flu_covid_sick.jpg
Share on Twitter Share on Facebook Share on Linkedin

Flu season is raging in the US—and hospitalizations are rising

Share on Twitter Share on Facebook Share on Linkedin
flu_covid_sick.jpg
This year’s flu season is underway in the United States, and the number of cases is rising, according to the latest flu data from the Centers for Disease Control and Prevention (CDC).
READ MORE >

Imaging-guided treatment for carpal tunnel syndrome provides long-term relief without surgery or hospitalization

Carpal tunnel syndrome can be successfully treated without surgery, according to new findings being presented at RSNA 2022 in Chicago. The procedure typically takes just 10 to 15 minutes.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Imaging-guided treatment for carpal tunnel syndrome provides long-term relief without surgery or hospitalization

Share on Twitter Share on Facebook Share on Linkedin
Carpal tunnel syndrome can be successfully treated without surgery, according to new findings being presented at RSNA 2022 in Chicago. The procedure typically takes just 10 to 15 minutes.
READ MORE >

NASA's Artemis 1 moon mission using phantom technology familiar to imaging specialists

Ehsan Samei, PhD, president-elect of the American Association of Physicists in Medicine, helped NASA build medical phantoms that are literally out of this world. Samei detailed the project at RSNA 2022 in Chicago. 

READ MORE >
Helga and Zohar, the phantom passengers, on the flight deck of the Orion spacecraft. NASA/LM/DLR photo
Share on Twitter Share on Facebook Share on Linkedin

NASA's Artemis 1 moon mission using phantom technology familiar to imaging specialists

Share on Twitter Share on Facebook Share on Linkedin
Helga and Zohar, the phantom passengers, on the flight deck of the Orion spacecraft. NASA/LM/DLR photo
Ehsan Samei, PhD, president-elect of the American Association of Physicists in Medicine, helped NASA build medical phantoms that are literally out of this world. Samei detailed the project at RSNA 2022 in Chicago. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme